Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesReversible cardiogenic shock following 5-Fluorouracil infusion
Investigational New Drugs, 06/12/09
Ferte C et al. - 5-fluorouracil remains a major component of chemotherapy regimens for various tumors. The authors report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.
Related Articles
A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer
Anti-Cancer Drugs, 10/15/09
Relevance Score: 67%
Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced well differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network.
BMC Cancer, 11/09/09
Relevance Score: 66%
Intrathecal infusions for intractable cancer pain: A qualitative study of the impact on a case series of patients and caregivers
Pain Research and Management, 10/28/09
Relevance Score: 45%
Propofol infusion syndrome in patients with refractory status epilepticus: An 11-year clinical experience
Critical Care Medicine, 11/19/09
Relevance Score: 44%
Use of intravenous infusion sedation among mechanically ventilated patients in the United States
Critical Care Medicine, 11/19/09
Relevance Score: 44%
Today in Heart Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost of treating heart failure in an Irish teaching hospital
Irish Journal of Medical Science, 12/18/09
Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non ischemic refractory heart failure
International Journal of Cardiology, 12/15/09
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition
International Journal of Cardiology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor